Skechers Gets IBD Stock Rating Upgrade

On Monday, Skechers (SKX) got an upgrade for its IBD SmartSelect Composite Rating from 90 to 96.


The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength.

Skechers is trading within the buy zone from a 53.24 entry from a flat base.

Looking For The Best Stocks To Buy And Watch? Start Here


One weak spot is the company’s 70 EPS Rating, which tracks quarterly and annual earnings-per-share growth. Look for that to improve to 80 or better to show it’s in the top 20% of all stocks.

Its Accumulation/Distribution Rating of A- shows heavy buying by institutional investors, such as mutual funds and pension funds, over the last 13 weeks.

The company reported 267% earnings-per-share growth for Q2. That marks four straight quarters of rising EPS growth. Sales growth climbed 127%, up from 15% in the prior quarter. The company has now posted increasing growth in each of the last four reports.

Skechers earns the No. 5 rank among its peers in the Apparel-Shoes & Related industry group. Crocs (CROX) is the top-ranked stock within the group.


Which Companies Are Now Outperforming 95% Of All Stocks?

See Which Stocks Just Came On — And Off — IBD’s Top Stock Lists

Find Top Stocks Near A Buy Point With IBD Leaderboard

Most Related Links :
reporterwings Governmental News Finance News

Source link

Back to top button